Publications by authors named "Jan Bussink"

Claim this Profile
A
A systematic review and quality of reporting checklist for repeatability and reproducibility of radiomic features.
Elisabeth Pfaehler, Ivan Zhovannik, Lise Wei, Ronald Boellaard, Andre Dekker, Jan Bussink

Phys Imaging Radiat Oncol· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Role of Hypoxia and the Immune System in Tumor Radioresistance.
Paul N Span, Jan Bussink

Cancers (Basel)· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HPV, hypoxia and radiation response in head and neck cancer.
Eva-Leonne Göttgens, Christian Ostheimer, Paul N Span, Jan Bussink, Ester M Hammond

Br J Radiol· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of symptomatic brain metastases after chemoradiotherapy for stage III non-small cell lung cancer: Does the type of chemotherapy regimen matter?
Lizza E L Hendriks, -Anita J W M Brouns, Mohammad Amini, Wilma Uyterlinde, Robin Wijsman, Jan Bussink

Lung Cancer· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Update on F-18-fluoro-deoxy-glucose-PET/computed tomography in nonsmall cell lung cancer.
Edwin A Usmanij, Lioe-Fee de Geus-Oei, Jan Bussink, Wim J G Oyen

Curr Opin Pulm Med· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In response to "histopathologic validation of 3'-deoxy-3'-(18)F-fluorothymidine PET for detecting tumour repopulation during fractionated radiotherapy in human FaDu squamous cell carcinoma in nude mice".
Esther G C Troost, Bianca A W Hoeben, Peter Laverman, Jan Bussink, Wim J G Oyen

Radiother Oncol· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In-treatment assessment of response in locally advanced NSCLC: paving the way for personalized medicine.
Edwin A Usmanij, Jan Bussink, Lioe-Fee de Geus-Oei

Lung Cancer· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The effect of carbogen breathing and nicotinamide added to standard (chemo)radiation treatment of advanced cervical cancer in Indonesia.
Willem Jan van Weelden, Sri Mutya Sekarutami, Ruud L M Bekkers, Johannes H Kaanders, Jan Bussink

Int J Gynecol Cancer· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and efficacy of sequential chemotherapy with carboplatin plus gemcitabine followed by weekly paclitaxel in advanced non-small cell lung cancer.
Patricia M M B Soetekouw, Johanna N H Timmer-Bonte, Miep A van der Drift, Frank van Leeuwen, Michiel Wagenaar, Jan Bussink

Int J Clin Oncol· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High NOTCH activity induces radiation resistance in non small cell lung cancer.
Jan Theys, Sanaz Yahyanejad, Roger Habets, Paul Span, Ludwig Dubois, Jan Bussink

Radiother Oncol· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of cetuximab and fractionated irradiation on tumour micro-environment.
Alina Santiago, Wolfgang Eicheler, Jan Bussink, Paul Rijken, Ala Yaromina

Radiother Oncol· November 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Thymidine analogues to assess microperfusion in human tumors.
Hilde L Janssen, Anna S Ljungkvist, Paul F Rijken, Debbie Sprong, Jan Bussink

Int J Radiat Oncol Biol Phys· July 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Role of FDG-PET in the diagnosis and management of lung cancer.
Wim J G Oyen, Jan Bussink, Ad F T Verhagen, Frans H M Corstens, Gerben P Bootsma

Expert Rev Anticancer Ther· August 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vascular endothelial growth factor independently predicts the efficacy of postoperative radiotherapy in node-negative breast cancer patients.
Peggy Manders, Fred C G J Sweep, Vivianne C G Tjan-Heijnen, Anneke Geurts-Moespot, Doorléne T H van Tienoven, Jan Bussink

Clin Cancer Res· December 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis